Stacie Rolland, NP
Family · Leesburg, GANPI 1124620935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 25.4% of the total. Reporting peaked in 2022 at $911 and has fallen 97.8% since, to $21 in 2024.
Across 103 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$443
- GSK$371
- AbbVie$174
- Lilly USA, LLC$163
- Pfizer$155
- AstraZeneca$117
- plus $321 from 12 others
What the payments were for
- Food & beverage$1,745100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $443 |
| GSK | 22 | $371 |
| AbbVie | 11 | $174 |
| Lilly USA, LLC | 11 | $163 |
| Pfizer | 9 | $155 |
| AstraZeneca | 3 | $117 |
| Boehringer Ingelheim | 5 | $86 |
| Bayer | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Merck | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $10 |
How this compares
$1,745 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Leesburg
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.